Skip to main content
Clinical Trials/ISRCTN16276576
ISRCTN16276576
Completed
未知

Assessment of the impact of national breast cancer screening program in achieving downstaging of breast cancer and improving quality of life of breast cancer patients in Morocco

International Agency For Research On Cancer0 sites1,081 target enrollmentJuly 16, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Breast cancer
Sponsor
International Agency For Research On Cancer
Enrollment
1081
Status
Completed
Last Updated
last year

Overview

Brief Summary

2024 Results article in https://pubmed.ncbi.nlm.nih.gov/38837217/ (added 11/07/2024)

Registry
who.int
Start Date
July 16, 2019
End Date
June 30, 2022
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
International Agency For Research On Cancer

Eligibility Criteria

Inclusion Criteria

  • Women registered with the histopathology diagnosis of breast cancer at the designated cancer centre(s) during the study period

Exclusion Criteria

  • Women in whom the final histopathology diagnosis will be benign disease; recurrent breast cancers

Outcomes

Primary Outcomes

Not specified

Similar Trials